Jump Financial LLC Sells 2,520 Shares of Mettler-Toledo International, Inc. $MTD

Jump Financial LLC lowered its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 90.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 280 shares of the medical instruments supplier's stock after selling 2,520 shares during the period. Jump Financial LLC's holdings in Mettler-Toledo International were worth $331,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in MTD. Greenleaf Trust grew its position in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after buying an additional 10 shares in the last quarter. Brooklyn Investment Group lifted its position in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock valued at $104,000 after acquiring an additional 10 shares during the period. Albion Financial Group UT grew its holdings in shares of Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the period. Finally, TD Private Client Wealth LLC raised its stake in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after purchasing an additional 11 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on MTD. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Bank of America raised their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Evercore ISI dropped their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Citigroup boosted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Finally, Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

Mettler-Toledo International Trading Up 1.3%

MTD stock traded up $16.86 during midday trading on Friday, hitting $1,304.65. The stock had a trading volume of 95,040 shares, compared to its average volume of 128,164. The firm has a market cap of $26.88 billion, a P/E ratio of 33.04, a price-to-earnings-growth ratio of 3.86 and a beta of 1.37. The business has a fifty day moving average price of $1,251.17 and a two-hundred day moving average price of $1,186.88. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the company posted $9.65 EPS. The business's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the sale, the chief financial officer owned 5,095 shares of the company's stock, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 in the last quarter. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.